Clinical Trial

cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia

Study acronym: OPTION-A
Recruiting
View on ClinicalTrials.gov →
Summary
Subjects enrolled in the OPTION-A study will be clinically indicated for atrial fibrillation (AF) ablation procedure with the FARAPULSE™ PFA system and treatment with WATCHMAN LAAC Device, per physician's medical judgement and according to hospitals' standard of care during the same procedure.
Protocol Amendment History 2 changes
notable Trial sites expanded: 34 -> 37 locations 2026-05-15
notable Trial sites expanded: 30 -> 34 locations 2026-05-09
Trial Details
NCT Number NCT06686485
Lead Sponsor Boston Scientific Corporation
Conditions Concomitant Procedures, Atrial Fibrillation, PFA, LAAC
Enrollment 433 participants
Start Date 2025-03-18
Primary Completion 2026-10-31 (estimated)
Study Completion 2029-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-23